Literature DB >> 22132889

Essential role of the adaptor protein Nck1 in Jurkat T cell activation and function.

I Yiemwattana1, J Ngoenkam, P Paensuwan, R Kriangkrai, B Chuenjitkuntaworn, S Pongcharoen.   

Abstract

The non-catalytic region of tyrosine kinase (Nck) is proposed to play an essential role in T cell activation. However, evidence based on functional and biochemical studies has brought into question the critical function of Nck. Therefore, the aim of the present work was to investigate the role of Nck in T cell activation. To study this, the human Jurkat T cell line was used as a model for human T lymphocytes. The short interfering (si) RNA targeting Nck1 gene was used with electroporation to knock-down Nck1 protein expression in Jurkat T cells. Primary human CD4 T cells were also transfected with the siRNA of Nck1. The results showed that decreased Nck1 protein expression did not affect the apoptosis of the transfected Jurkat T cells compared with control siRNA-transfected cells and non-transfected cells. Upon CD3ε/CD28 stimulation, knock-down of Nck1 in Jurkat T cells caused a decrease in CD69 expression and in interleukin (IL)-2 secretion. Similarly, knock-down of Nck1 in primary CD4 T cells also caused decreased CD69 expression. However, no significant alterations of CD69 and IL-2 expression were found upon phytohaemagglutinin (PHA)/phorbol myristate acetate (PMA) stimulation. Knock-down of Nck1 had no effect on the proliferation of Jurkat T cells stimulated with either PHA or anti-T cell receptor (TCR) monoclonal antibody (C305). The reduced Nck1 expression in Jurkat cells was also associated with a reduced phosphorylation of extracellular regulated kinase (Erk)1 and Erk2 proteins upon CD3ε/CD28 stimulation. In conclusion, the decreased Nck1 protein in Jurkat T cells resulted in an impairment of TCR-CD3-mediated activation involving a defective Erk phosphorylation pathway.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22132889      PMCID: PMC3248091          DOI: 10.1111/j.1365-2249.2011.04494.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

Review 2.  The Nck family of adapter proteins: regulators of actin cytoskeleton.

Authors:  László Buday; Livius Wunderlich; Peter Tamás
Journal:  Cell Signal       Date:  2002-09       Impact factor: 4.315

3.  Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation.

Authors:  Diana Gil; Wolfgang W A Schamel; María Montoya; Francisco Sánchez-Madrid; Balbino Alarcón
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

Review 4.  Differential signaling by lymphocyte antigen receptors.

Authors:  J Alberola-Ila; S Takaki; J D Kerner; R M Perlmutter
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.

Authors:  Masa Sasagawa; Nadja B Cech; Dean E Gray; Gary W Elmer; Cynthia A Wenner
Journal:  Int Immunopharmacol       Date:  2006-03-07       Impact factor: 4.932

6.  The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Authors:  Pankaj Tailor; Sue Tsai; Afshin Shameli; Pau Serra; Jinguo Wang; Stephen Robbins; Masao Nagata; Andrea L Szymczak-Workman; Dario A A Vignali; Pere Santamaria
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7.

Authors:  Brandon E Kremer; Laura A Adang; Ian G Macara
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

8.  Nckbeta adapter controls neuritogenesis by maintaining the cellular paxillin level.

Authors:  Shengxi Guan; Mei Chen; David Woodley; Wei Li
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

9.  T cell receptor signalling.

Authors:  J Lin; A Weiss
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.

Authors:  J Zhang; A Shehabeldin; L A da Cruz; J Butler; A K Somani; M McGavin; I Kozieradzki; A O dos Santos; A Nagy; S Grinstein; J M Penninger; K A Siminovitch
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  8 in total

1.  Nck recruitment to the TCR required for ZAP70 activation during thymic development.

Authors:  Aldo Borroto; Irene Arellano; Elaine P Dopfer; Marek Prouza; Miloslav Suchànek; Manuel Fuentes; Alberto Orfao; Wolfgang W Schamel; Balbino Alarcón
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

2.  Ovalbumin Antigen-Specific Activation of Human T Cell Receptor Closely Resembles Soluble Antibody Stimulation as Revealed by BOOST Phosphotyrosine Proteomics.

Authors:  Xien Yu Chua; Arthur Salomon
Journal:  J Proteome Res       Date:  2021-05-21       Impact factor: 5.370

3.  T cell specific adaptor protein (TSAd) promotes interaction of Nck with Lck and SLP-76 in T cells.

Authors:  Cecilie Dahl Hem; Vibeke Sundvold-Gjerstad; Stine Granum; Lise Koll; Greger Abrahamsen; Laszlo Buday; Anne Spurkland
Journal:  Cell Commun Signal       Date:  2015-07-11       Impact factor: 5.712

4.  Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation.

Authors:  Jatuporn Ngoenkam; Pussadee Paensuwan; Kanlaya Preechanukul; Boonruang Khamsri; Ichaya Yiemwattana; Esmeralda Beck-García; Susana Minguet; Wolfgang W A Schamel; Sutatip Pongcharoen
Journal:  Cell Commun Signal       Date:  2014-03-26       Impact factor: 5.712

5.  Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.

Authors:  Madison Black; Ivraym B Barsoum; Peter Truesdell; Tiziana Cotechini; Shannyn K Macdonald-Goodfellow; Margaret Petroff; D Robert Siemens; Madhuri Koti; Andrew W B Craig; Charles H Graham
Journal:  Oncotarget       Date:  2016-03-01

6.  Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Authors:  Philip J Law; Amit Sud; Jonathan S Mitchell; Marc Henrion; Giulia Orlando; Oleg Lenive; Peter Broderick; Helen E Speedy; David C Johnson; Martin Kaiser; Niels Weinhold; Rosie Cooke; Nicola J Sunter; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; Jonathan Carmichael; James R Bailey; Guy Pratt; Thahira Rahman; Chris Pepper; Chris Fegan; Elke Pogge von Strandmann; Andreas Engert; Asta Försti; Bowang Chen; Miguel Inacio da Silva Filho; Hauke Thomsen; Per Hoffmann; Markus M Noethen; Lewin Eisele; Karl-Heinz Jöckel; James M Allan; Anthony J Swerdlow; Hartmut Goldschmidt; Daniel Catovsky; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

7.  Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain.

Authors:  Kirsten Richter; Arne C Rufer; Magali Muller; Dominique Burger; Fabio Casagrande; Tabea Grossenbacher; Sylwia Huber; Melanie N Hug; Philipp Koldewey; Andrea D'Osualdo; Daniel Schlatter; Theodor Stoll; Markus G Rudolph
Journal:  J Biol Chem       Date:  2020-04-21       Impact factor: 5.157

8.  Downregulation of Nck1 After Spinal Cord Injury in Adult Rats

Authors:  RiYun Yang; Long Zhao; JingYin Bao; YongJiang Wu; PanHui Xia; JingYing Pan
Journal:  Balkan Med J       Date:  2021-12-20       Impact factor: 2.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.